LDH isozyme as a prognostic factor for patients with metastatic clear cell renal cell carcinoma (mCRCC)

被引：0
|
作者：
Takeda, H. [1 ]
Kimura, G. [1 ]
Taniuchi, M. [1 ]
Hasegawa, H. [1 ]
Mikami, H. [1 ]
Akatsuka, J. [1 ]
Endo, Y. [1 ]
Toyama, Y. [1 ]
Kondo, Y. [1 ]
机构：
[1] Nippon Med Sch, Main Hosp, Urol Dept, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.755
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
251P
引用
收藏
页码：S1570 / S1570
页数：1
相关论文
共 50 条
  • [41] PROGNOSTIC IMPACT OF PATHOLOGICAL RENAL PARENCHYMAL INFILTRATION IN NON-METASTATIC CLEAR CELL RENAL CELL CARCINOMA
    Tanaka, Hajime
    Fukawa, Yuki
    Yamamoto, Kouhei
    Fukuda, Shohei
    Uehara, Sho
    Yoshida, Soichiro
    Yokoyama, Minato
    Matsuoka, Yoh
    Campbell, Steven C.
    Fujii, Yasuhisa
    JOURNAL OF UROLOGY, 2022, 207 (05): : E863 - E863
  • [42] THE NUMBER OF METABOLIC FEATURES AS A SIGNIFICANT PROGNOSTIC FACTOR IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
    Ye, Chang Hee
    Byun, Seok Soo
    Hong, Sung Kyu
    Lee, Hak Min
    Yuk, Hyeong Dong
    Yu, Ji Hyeong
    Cho, Dae Yeon
    Sung, Luck Hee
    Chung, Jae Yong
    JOURNAL OF UROLOGY, 2020, 203 : E1227 - E1227
  • [43] The number of metabolic features as a significant prognostic factor in patients with metastatic renal cell carcinoma
    Yuk, Hyeong Dong
    Hwang, Eu Chang
    Park, Jae Young
    Jeong, Chang Wook
    Song, Cheryn
    Seo, Seong Il
    Byun, Seok-Soo
    Kwak, Cheol
    Hong, Sung-Hoo
    Kang, Minyong
    Chung, Jinsoo
    Lee, Hakmin
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [44] The number of metabolic features as a significant prognostic factor in patients with metastatic renal cell carcinoma
    Hyeong Dong Yuk
    Eu Chang Hwang
    Jae Young Park
    Chang Wook Jeong
    Cheryn Song
    Seong Il Seo
    Seok-Soo Byun
    Cheol Kwak
    Sung-Hoo Hong
    Minyong Kang
    Jinsoo Chung
    Hakmin Lee
    Scientific Reports, 10
  • [45] The number of metabolic features as a significant prognostic factor in patients with metastatic renal cell carcinoma
    Lee, D.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 41 - 41
  • [46] Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma
    Del Vecchio, Sharon J.
    Ellis, Robert J.
    JOURNAL OF KIDNEY CANCER AND VHL, 2018, 5 (04): : 1 - 5
  • [47] Pharmacotherapy for treating metastatic clear cell renal cell carcinoma
    Porta, Camillo
    Chiellino, Silvia
    Ferrari, Alessandra
    Mariucci, Sara
    Liguigli, Wanda
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (02) : 205 - 216
  • [48] Adipophilin as prognostic biomarker in clear cell renal cell carcinoma
    Tolkach, Yuri
    Lueders, Christine
    Meller, Sebastian
    Jung, Klaus
    Stephan, Carsten
    Kristiansen, Glen
    ONCOTARGET, 2017, 8 (17) : 28672 - 28682
  • [49] Prognostic Role of Cell Cycle and Proliferative Biomarkers in Patients with Clear Cell Renal Cell Carcinoma
    Gayed, Bishoy A.
    Youssef, Ramy F.
    Bagrodia, Aditya
    Kapur, Payal
    Darwish, Oussama M.
    Krabbe, Laura-Maria
    Sagalowsky, Arthur
    Lotan, Yair
    Margulis, Vitaly
    JOURNAL OF UROLOGY, 2013, 190 (05): : 1662 - 1667
  • [50] Hepcidin as a prognostic biomarker in clear cell renal cell carcinoma
    Zhou, Zijian
    Wu, Jiajin
    Yang, Yuanyuan
    Gao, Peng
    Wang, Lujia
    Wu, Zhong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (09): : 4120 - +
12345